Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hazard Rate01:11

Hazard Rate

525
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
525
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

1.3K
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
1.3K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

333
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
333
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

492
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
492
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

426
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
426
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

955
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
955

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cancer risk with methotrexate-TNF antagonist combination therapy compared to TNF-antagonist monotherapy in IBD.

Inflammatory bowel diseases·2026
Same author

Toward Artificial Intelligence-driven Clinical Decision Support Tools in Rheumatology.

Rheumatic diseases clinics of North America·2026
Same author

Statistics and AI - A Fireside Conversation.

Harvard data science review·2026
Same author

Predicting the timing of first sustained cognitive worsening in Alzheimer's disease using real-world clinical data and machine learning.

medRxiv : the preprint server for health sciences·2026
Same author

Nonparametric estimation of the total treatment effect with multiple outcomes in the presence of terminal events.

Biometrics·2026
Same author

Stratification of Alzheimer's disease patients using knowledge-guided unsupervised latent factor clustering with electronic health record data.

Communications medicine·2026

Related Experiment Video

Updated: May 4, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

9.9K

Omnibus risk assessment via accelerated failure time kernel machine modeling.

Jennifer A Sinnott1, Tianxi Cai

  • 1Department of Biostatistics, Harvard School of Public Health, 655 Huntington Avenue, Boston, Massachusetts 02115, U.S.A.

Biometrics
|December 17, 2013
PubMed
Summary

This study introduces new kernel machine (KM) regression methods for predicting disease outcomes using genomic data. These advanced statistical learning techniques improve risk prediction accuracy by capturing complex gene interactions and non-linear effects.

Keywords:
Accelerated failure time modelKernel machinesOmnibus testResamplingRisk predictionSurvival analysis

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.3K
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

3.1K

Related Experiment Videos

Last Updated: May 4, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

9.9K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.3K
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

3.1K

Area of Science:

  • Genomics
  • Biostatistics
  • Medical Informatics

Background:

  • Integrating genomic data with clinical factors can enhance disease outcome prediction but is challenging due to marker complexity.
  • Traditional methods may miss non-linear or interactive effects of genetic markers.
  • Kernel machine (KM) frameworks offer a way to model non-linear relationships.

Purpose of the Study:

  • To develop and validate kernel machine regression methods for survival outcomes under the accelerated failure time (AFT) model.
  • To propose robust testing and estimation approaches for genomic risk prediction.
  • To improve the interpretability and reliability of disease outcome prediction models.

Main Methods:

  • Derived KM regression testing and prediction methods for the accelerated failure time (AFT) model.
  • Utilized resampling procedures to approximate the null distribution of test statistics.
  • Developed a robust Omnibus Test for combining information across multiple kernels and a kernel selection approach.

Main Results:

  • The proposed methods provide accurate risk prediction by incorporating genomic information.
  • The Omnibus Test effectively combines information from multiple kernels.
  • Kernel selection approach identifies the most suitable kernel for estimation.

Conclusions:

  • The developed KM regression methods under the AFT model offer a powerful alternative for disease outcome prediction.
  • These methods can better capture complex genomic interactions than traditional approaches.
  • The approach is validated through an application in breast cancer risk prediction.